Company
Fresenius Biotech develops and markets biopharma-ceuticals for the effective treatment of severe diseases.
...
more
Transplantation
ATG Fresenius S®, a polyclonal antibody, is successfully marketed in over 60 countries.
...
more
Oncology
We develop and market innovative antibody therapies for the treatment of cancer. We recently launched
Removab®, a trifunctional antibody indicated for the treatment of malignant ascites.
...
more
